Edit |   |
---|---|
Antigenic Specificity | CALCA/CGRP1/CALCB/CGRP2 (Galcanezumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Galcanezumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CALCA/CGRP1/CALCB/CGRP2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. LY2951742/galcanezumab is a fully humanized monoclonal antibody against human calcitonin gene-related peptide (CGRP) that is developed by ELi Lilly and Company. This therapy is given as a single subcutaneous injection twice a month and ongoing clinical trials for the agent are for episodic and chronic migraine as well as cluster headaches. |
Immunogen | n/a |
Other Names | Galcanezumab, CALCA/CGRP1/CALCB/CGRP2, 1578199-75-3 |
Gene, Accession # | CAS: 1578199-75-3 |
Catalog # | abx831382 |
Price | please inquire |
Order / More Info | CALCA/CGRP1/CALCB/CGRP2 (Galcanezumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950